178 related articles for article (PubMed ID: 6358156)
61. Misonidazole in radiotherapy of supratentorial malignant brain gliomas in adult patients: a randomized double-blind study.
Eur J Cancer Clin Oncol; 1983 Jan; 19(1):39-42. PubMed ID: 6343091
[TBL] [Abstract][Full Text] [Related]
62. [Results of percutaneous radiotherapy of bladder cancer using 1 and 2 series of irradiation].
Kob D; Arndt J; Kriester A; Schwenk M; Kloetzer KH
Strahlentherapie; 1985 Nov; 161(11):673-7. PubMed ID: 3907021
[TBL] [Abstract][Full Text] [Related]
63. Increased enhancement of tumour response to X-rays and high-LET neon ions by desmethylmisonidazole relative to misonidazole.
Tenforde TS; Curtis SB; Parr SS; Afzal SM; Howard J; Lyman JT
Int J Radiat Biol Relat Stud Phys Chem Med; 1982 Jun; 41(6):677-84. PubMed ID: 6981621
[No Abstract] [Full Text] [Related]
64. Misonidazole and unconventional radiation in advanced squamous cell carcinoma of the esophagus: a phase II study of the Radiation Therapy Oncology Group.
Ydrach AA; Marcial VA; Parsons J; Concannon J; Asbell SO; George F
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):357-9. PubMed ID: 6809704
[TBL] [Abstract][Full Text] [Related]
65. A phase III randomized study of misonidazole plus radiation vs. radiation alone for cervix cancer.
Chan P; Milosevic M; Fyles A; Carson J; Pintilie M; Rauth M; Thomas G
Radiother Oncol; 2004 Mar; 70(3):295-9. PubMed ID: 15064016
[TBL] [Abstract][Full Text] [Related]
66. Hypoxic cell radiosensitizers: expectations and progress in drug development.
Coleman CN
Int J Radiat Oncol Biol Phys; 1985 Feb; 11(2):323-9. PubMed ID: 3156109
[TBL] [Abstract][Full Text] [Related]
67. A phase I/II study of the hypoxic cell sensitizer misonidazole as an adjunct to high fractional dose radiotherapy in patients with unresectable squamous cell carcinoma of the head and neck: a RTOG randomized study (#79-04).
Lee DJ; Pajak TF; Stetz J; Order SE; Weissberg JB; Fischer JJ
Int J Radiat Oncol Biol Phys; 1989 Feb; 16(2):465-70. PubMed ID: 2646255
[TBL] [Abstract][Full Text] [Related]
68. The Medical Research Council trial of misonidazole in carcinoma of the uterine cervix. A report from the MRC Working Party on misonidazole for cancer of the cervix.
Br J Radiol; 1984 Jun; 57(678):491-9. PubMed ID: 6372930
[TBL] [Abstract][Full Text] [Related]
69. Influence of misonidazole on the radiosensitivity of transplantable transitional cell bladder carcinoma in mice.
Hampel N; Persky L
Invest Urol; 1981 Jul; 19(1):14-6. PubMed ID: 7251317
[TBL] [Abstract][Full Text] [Related]
70. Addition of misonidazole, etanidazole, or hyperthermia to treatment with fluosol-DA/carbogen/radiation.
Teicher BA; Herman TS; Holden SA; Jones SM
J Natl Cancer Inst; 1989 Jun; 81(12):929-34. PubMed ID: 2525198
[TBL] [Abstract][Full Text] [Related]
71. [Postoperative radiotherapy of astrocytomas grade 3 and 4 with the radiosensitizer misonidazole. -End results of a multicentric controlled German study].
Sack H; Calcanis A; Godehardt E; Weidtman V; Zülch KJ; Ammon J; Bamberg M; Herbst M; Keim H; Kleibel F; Makoski HB; Potthoff PC; Schlegel G; Schnepper E
Strahlentherapie; 1982 Aug; 158(8):466-9. PubMed ID: 6753245
[TBL] [Abstract][Full Text] [Related]
72. Potentiation of cyclophosphamide cytotoxicity in vivo: a study with misonidazole and fifteen other 1-substituted 2-nitroimidazoles.
Chaplin DJ; Sheldon PW; Ahmed I; Adams GE
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1647-51. PubMed ID: 6480452
[TBL] [Abstract][Full Text] [Related]
73. Radiation therapy of rat brain tumor using misonidazole as hypoxic cell sensitizer.
Tamura M; Inoue H; Murata M; Koizumi H; Nakamura M; Yonome I; Niibe H
J Cancer Res Clin Oncol; 1985; 109(3):188-92. PubMed ID: 4008513
[TBL] [Abstract][Full Text] [Related]
74. Radical irradiation and misonidazole in the treatment of advanced cervical carcinoma: results of a phase II trial.
Girinski T; Pejovic MH; Haie C; Bonnay M; Gerbaulet A; Mazeron JJ; Malaise E; Chassagne D
Int J Radiat Oncol Biol Phys; 1985 Oct; 11(10):1783-7. PubMed ID: 4044341
[TBL] [Abstract][Full Text] [Related]
75. Radiation therapy alone or combined with misonidazole in the treatment of locally advanced non-oat cell lung cancer: report of an RTOG prospective randomized trial.
Simpson JR; Bauer M; Perez CA; Wasserman TH; Emami B; Doggett RL; Byhardt RW; Phillips TL; Mowry PA
Int J Radiat Oncol Biol Phys; 1989 Jun; 16(6):1483-91. PubMed ID: 2542197
[TBL] [Abstract][Full Text] [Related]
76. Broad-shouldered survival curves of a human melanoma xenograft. Implications for radiation therapy in the absence and presence of misonidazole.
Rofstad EK; Brustad T
Acta Radiol Oncol; 1981; 20(4):261-5. PubMed ID: 6277155
[TBL] [Abstract][Full Text] [Related]
77. Intravesical administration of misonidazole in bladder carcinoma.
Ghoneim MA; Shaaban AA; El-Merzabani MM; Awaad HK; El Gammal S
Acta Radiol Oncol; 1983; 22(3):177-81. PubMed ID: 6312756
[TBL] [Abstract][Full Text] [Related]
78. Late results of multiple fractions per day (MFD) with misonidazole in advanced cancer of the head and neck. A pilot study of the EORTC radiotherapy group.
Van den Bogaert W; van der Schueren E; Van Tongelen C; Horiot JC; Chaplain G; Arcangeli G; Gonzalez D; Svoboda V
Radiother Oncol; 1985 Feb; 3(2):139-44. PubMed ID: 3983422
[TBL] [Abstract][Full Text] [Related]
79. [Radiosensitizing effect of misonidazole on intracranially transplanted tumors in mice and its clinical application (author's transl)].
Otsuka S; Suda K; Yumitori K; Yamashita J; Oda Y; Takeuchi J; Handa H; Ono K
Neurol Med Chir (Tokyo); 1982 May; 22(5):337-43. PubMed ID: 6180334
[No Abstract] [Full Text] [Related]
80. A comparative investigation of nimorazole and misonidazole as hypoxic radiosensitizers in a C3H mammary carcinoma in vivo.
Overgaard J; Overgaard M; Nielsen OS; Pedersen AK; Timothy AR
Br J Cancer; 1982 Dec; 46(6):904-11. PubMed ID: 7150484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
